Arcadia Biosciences, Inc.
RKDA· Nasdaq
Released Mar 27, 2019, after the close
10-K filed Apr 1, 2019, 91 days after period end · 0001564590-19-010452
derived · Computed from the longer spans the company filed.
| Metric | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures |
|---|---|---|---|---|
| Revenue | $444.00K | $1.43M | $540.00K | $1.35M |
| Net Income | -$646.00K |
Arcadia Biosciences, Inc. · CIK 1469443 · Engraved from SEC EDGAR
| -$2.96M |
| -$5.71M |
| -$3.86M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.